Evidence map›Paper›PMID 34681671›Full record

ArticleInternational journal of molecular sciences2021

Sulfonated and Carboxymethylated β-Glucan Derivatives with Inhibitory Activity against Herpes and Dengue Viruses.

José Louzinho Lopes, Vinicius Seiki Takemura Quinteiro, Jéssica Wouk, Maria Laura Darido, Robert F H Dekker, Aneli M Barbosa-Dekker, Václav Vetvicka, Mário A A Cunha, Ligia Carla Faccin-Galhardi, Alexandre Orsato

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Anti-HSV-1 agents: an update.Frontiers in pharmacology · 2024
    Review
  4. Article
  5. Glucans, Paramylon and Other Algae Bioactive Molecules.International journal of molecular sciences · 2023
    Article
  6. Review
  7. In Vitro Anti-HIV-1 Activity of Chitosan OligomersBiotech (Basel (Switzerland)) · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

José Louzinho LopesLaboratory of Synthesis of Medicinal Molecules (LaSMMed), Department of Chemistry, CCE, Universidade Estadual de Londrina, Londrina CEP 86057-970, Parana, Brazil.ORCID 0000-0002-1245-1533
Vinicius Seiki Takemura QuinteiroLaboratory of Synthesis of Medicinal Molecules (LaSMMed), Department of Chemistry, CCE, Universidade Estadual de Londrina, Londrina CEP 86057-970, Parana, Brazil.
Jéssica WoukLaboratory of Virology, Department of Microbiology, CCB, Universidade Estadual de Londrina, Londrina CEP 86057-970, Parana, Brazil.
Maria Laura DaridoLaboratory of Virology, Department of Microbiology, CCB, Universidade Estadual de Londrina, Londrina CEP 86057-970, Parana, Brazil.
Robert F H DekkerBeta-Glucan Produtos Farmoquímicos EIRELI, Lote 24A, Bloco Zircônia, Universidade Tecnológica Federal do Paraná, Câmpus Londrina, Londrina CEP 86036-700, Parana, Brazil.ORCID 0000-0002-3787-6917
Aneli M Barbosa-DekkerLaboratory of Synthesis of Medicinal Molecules (LaSMMed), Department of Chemistry, CCE, Universidade Estadual de Londrina, Londrina CEP 86057-970, Parana, Brazil.
Václav VetvickaDepartment of Pathology and Laboratory Medicine, University of Louisville, Louisville, KY 40292, USA.ORCID 0000-0002-3227-2938
Mário A A CunhaDepartment of Chemistry, Universidade Tecnológica Federal do Paraná, Pato Branco CEP 85503-390, Parana, Brazil.
Ligia Carla Faccin-GalhardiLaboratory of Virology, Department of Microbiology, CCB, Universidade Estadual de Londrina, Londrina CEP 86057-970, Parana, Brazil.
Alexandre OrsatoLaboratory of Synthesis of Medicinal Molecules (LaSMMed), Department of Chemistry, CCE, Universidade Estadual de Londrina, Londrina CEP 86057-970, Parana, Brazil.ORCID 0000-0001-7379-126X
Universidade Estadual de Londrina · BRUniversidade Tecnológica Federal do Paraná · BRUniversity of Louisville · US

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 001Fundação Araucária 88882.448082/2019-01National Council for Scientific and Technological Development 309717/2015-9National Council for Scientific and Technological Development 409016/2016-0National Council for Scientific and Technological Development 88881.362216/2019-01
6 · The paper itself

Abstract

The infection of mammalian cells by enveloped viruses is triggered by the interaction of viral envelope glycoproteins with the glycosaminoglycan, heparan sulfate. By mimicking this carbohydrate, some anionic polysaccharides can block this interaction and inhibit viral entry and infection. As heparan sulfate carries both carboxyl and sulfate groups, this work focused on the derivatization of a (1→3)(1→6)-β-D-glucan, botryosphaeran, with these negatively-charged groups in an attempt to improve its antiviral activity. Carboxyl and sulfonate groups were introduced by carboxymethylation and sulfonylation reactions, respectively. Three derivatives with the same degree of carboxymethylation (0.9) and different degrees of sulfonation (0.1; 0.2; 0.4) were obtained. All derivatives were chemically characterized and evaluated for their antiviral activity against herpes (HSV-1, strains KOS and AR) and dengue (DENV-2) viruses. Carboxymethylated botryosphaeran did not inhibit the viruses, while all sulfonated-carboxymethylated derivatives were able to inhibit HSV-1. DENV-2 was inhibited only by one of these derivatives with an intermediate degree of sulfonation (0.2), demonstrating that the dengue virus is more resistant to anionic β-D-glucans than the Herpes simplex virus. By comparison with a previous study on the antiviral activity of sulfonated botryosphaerans, we conclude that the presence of carboxymethyl groups might have a detrimental effect on antiviral activity.

Indexed as

AnimalsAntiviral Agentsbeta-GlucansCell SurvivalChlorocebus aethiopsDengue VirusGlucansHerpesviridaeMethylationSulfonic AcidsVero CellsVirus InternalizationAntiviral Agentsbeta-GlucansbotryosphaeranGlucansSulfonic Acids(1→3)(1→6)-β-D-glucananionic polysaccharidesantiviralsdengue virusherpes simplex virus

Identifiers

PMID34681671
PMCPMC8538634
OpenAlexW3205045384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.